There was a little more volume then usual in yesterday's session,although the share price remained in the trading range.
Perhaps the success in Dimerx prompted more interest in other drug development companies.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-31
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.5¢ |
Change
-0.001(1.16%) |
Mkt cap ! $23.30M | |||
| Open | High | Low | Value | Volume |
| 8.6¢ | 8.8¢ | 8.5¢ | $14.30K | 167.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 8.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.0¢ | 134334 | 1 |
View Market Depth
| Last trade - 10.49am 31/07/2024 (20 minute delay) ? |
| ATX (ASX) Chart |